Business

  • UK health tech leaders bring cutting-edge innovations to Global Health

    AI-powered wellness ecosystems, cloud-native imaging platforms, digital hospital management solutions, advanced medical gas systems, and world-leading clinical education programmes are among the innovations being showcased this year on the UK Pavilion at the Global Health Exhibition 2025. Taking place from 27–30 October in Riyadh, Saudi Arabia, the exhibition will welcome over 160,000 healthcare professionals, 2,000 [...]

  • Imprivata acquires Verosint to add AI-powered risk signalling to Enterprise Access Management platform 

    Imprivata has announced the acquisition of Verosint, a leader in Identity Threat Detection and Response (ITDR) solutions. The acquisition represents Imprivata’s latest strategic investment in modernising enterprise access management with solutions that deliver advanced, frictionless, and passwordless access for every user type, including frontline staff, knowledge workers, and third-party identities, while strengthening security, streamlining compliance, [...]

  • HPE Europe 2025: What to know, what’s next

    On September 25, hundreds of healthcare professionals, investors, and industry changemakers gathered in London for McDermott Will & Schulte’s annual Healthcare Private Equity (HPE) Europe conference. Keynote speakers Steph McGovern and Robert Peston, hosts of the hit UK podcast The Rest Is Money covering money, politics, and the markets, kicked off a high-impact event with remarks from [...]

  • Magentus expands UK presence in London and Manchester

    Global health technology company Magentus is strengthening its presence in UK healthcare by opening new offices in London and Manchester. Magentus has opened new offices in Farringdon London and at The Chancery in Manchester’s corporate centre, marking a significant milestone in Magentus’s strategic expansion across the UK. These hubs are designed to foster collaboration across [...]

  • AI could bring healthcare liability challenges, experts warn

    Artificial intelligence in healthcare could create complex legal challenges over who is responsible when medical failures occur, experts have warned. A new report raises concerns about who is accountable if patients are harmed by AI systems, along with issues such as limited effectiveness testing. The technology is being developed for clinical uses, including scan interpretation [...]

  • UK gov announces £50m mental health research boost

    The UK government has announced £50m in funding for mental health research that will place people with lived experience at the centre of developing new treatments. The Mental Health Goals programme aims to speed up the development of new medicines, technologies and therapies for conditions affecting one in four people in England. Poor mental health [...]

  • Highland to help companies seize ‘new era’ in health tech growth

    Health tech growth partner Highland has today revealed its new identity – reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and drive growth. Known for nearly a quarter of a century as Highland Marketing, the company has built a strong reputation for launching and championing many [...]

  • Signature Clinic expands with dedicated Liverpool location

    Signature Clinic, the UK’s largest provider of cosmetic surgery, is proud to announce the official opening of its brand-new, purpose-designed clinic in the heart of Liverpool. Following the success of operating as a satellite hub from Manchester since 2024, the demand from patients in Liverpool has been so strong that a fully dedicated clinic has [...]

  • A key Ozempic patent lapses in Canada: Deliberate or a mistake?

    By Reddie & Grose It is impossible to escape the headlines on GLP-1 agonists such as Ozempic and Wegovy. Therefore, it seems reasonable to assume that the innovator behind these blockbuster drugs has robust, fail-safe strategies to protect their intellectual property worldwide. However, inaction by Danish company Novo Nordisk, who manufactures Ozempic and Wegovy, has [...]

  • McDermott advises Sycamore Partners on acquisition of Walgreens Boots Alliance

    International law firm McDermott Will & Schulte advised Sycamore Partners, a leading New York-based private equity firm, as UK healthcare regulatory counsel on its acquisition of Walgreens Boots Alliance, Inc. The total transaction is valued at up to $23.7 billion. Sycamore Partners specialises in consumer, distribution and retail-related investments and partners with management teams to [...]